Works matching DE "EFAVIRENZ-emtricitabine-tenofovir (Drug)"
Results: 80
Urine assay for tenofovir to monitor adherence in real time to tenofovir disoproxil fumarate/emtricitabine as pre-exposure prophylaxis.
- Published in:
- HIV Medicine, 2017, v. 18, n. 6, p. 412, doi. 10.1111/hiv.12518
- By:
- Publication type:
- Article
Cost-effectiveness analysis of tenofovir/emtricitabine and abacavir/lamivudine in combination with efavirenz or atazanavir/ritonavir for treatment-naïve adults with HIV-1 infection in the UK, based on the AIDS Clinical Trials Group 5202 clinical trial
- Published in:
- HIV Medicine, 2016, v. 17, n. 7, p. 505, doi. 10.1111/hiv.12349
- By:
- Publication type:
- Article
Switching from a two-tablet regimen of tenofovir/emtricitabine and efavirenz to a one-tablet regimen may affect patients' perceptions and drug management.
- Published in:
- HIV Medicine, 2016, v. 17, n. 5, p. 390, doi. 10.1111/hiv.12345
- By:
- Publication type:
- Article
Viral and inflammatory markers in cerebrospinal fluid of patients with HIV-1-associated neurocognitive impairment during antiretroviral treatment switch.
- Published in:
- HIV Medicine, 2015, v. 16, n. 6, p. 388, doi. 10.1111/hiv.12243
- By:
- Publication type:
- Article
HIV nucleoside reverse transcriptase inhibitors efavirenz and tenofovir change the growth and differentiation of primary gingival epithelium.
- Published in:
- HIV Medicine, 2014, v. 15, n. 4, p. 196, doi. 10.1111/hiv.12100
- By:
- Publication type:
- Article
Pharmacokinetics of two common antiretroviral regimens in older HIV-infected patients: a pilot study Pharmacokinetics of two common antiretroviral regimens in older HIV-infected patients: a pilot study.
- Published in:
- HIV Medicine, 2013, v. 14, n. 7, p. 401, doi. 10.1111/hiv.12017
- By:
- Publication type:
- Article
Tenofovir DF/emtricitabine and efavirenz combination therapy for HIV infection in patients treated for tuberculosis: the ANRS 129 BKVIR trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Atazanavir Plus Ritonavir or Efavirenz as Part of a 3-Drug Regimen for Initial Treatment of HIV-1.
- Published in:
- Annals of Internal Medicine, 2011, v. 154, n. 7, p. 445, doi. 10.7326/0003-4819-154-7-201104050-00316
- By:
- Publication type:
- Article
Serum Nevirapine and Efavirenz Concentrations and Effect of Concomitant Rifampicin in HIV Infected Children on Antiretroviral Therapy.
- Published in:
- Indian Pediatrics, 2011, v. 48, n. 12, p. 943, doi. 10.1007/s13312-011-0153-3
- By:
- Publication type:
- Article
Bictegravir: First Global Approval.
- Published in:
- Drugs, 2018, v. 78, n. 5, p. 601, doi. 10.1007/s40265-018-0896-4
- By:
- Publication type:
- Article
Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Single-Tablet Regimen (Atripla): A Review of its Use in the Management of HIV Infection.
- Published in:
- Drugs, 2010, v. 70, n. 17, p. 2315, doi. 10.2165/11203800-000000000-00000
- Publication type:
- Article
Interaction of disulfiram with antiretroviral medications: Efavirenz increases while atazanavir decreases disulfiram effect on enzymes of alcohol metabolism.
- Published in:
- American Journal on Addictions, 2014, v. 23, n. 2, p. 137, doi. 10.1111/j.1521-0391.2013.12081.x
- By:
- Publication type:
- Article
Lack of Effect from a Previous Single Dose of Nevirapine on Virologic and Immunologic Responses After 6 Months of Antiretroviral Regimens Containing Either Efavirenz or Lopinavir-Ritonavir.
- Published in:
- Pharmacotherapy, 2011, v. 31, n. 2, p. 158, doi. 10.1592/phco.31.2.158
- By:
- Publication type:
- Article
Usefulness of Methadone Plasma Concentration Measurement in Patients Receiving Nevirapine or Efavirenz.
- Published in:
- American Journal of Drug & Alcohol Abuse, 2011, v. 37, n. 4, p. 264, doi. 10.3109/00952990.2011.591465
- By:
- Publication type:
- Article
Effect of Food on the Steady-State Pharmacokinetics of Tenofovir and Emtricitabine plus Efavirenz in Ugandan Adults.
- Published in:
- AIDS Research & Treatment, 2012, p. 1, doi. 10.1155/2012/105980
- By:
- Publication type:
- Article
Long-term efficacy and safety of E/C/F/TDF vs EFV/FTC/TDF and ATV+RTV+FTC/TDF in HIV-1-infected treatment-naïve subjects ≥50 years.
- Published in:
- Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19767
- By:
- Publication type:
- Article
Cost-effectiveness of DTG+ABC/3TC versus EFV/TDF/FTC for first-line treatment of HIV-1 in the United States.
- Published in:
- Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19605
- By:
- Publication type:
- Article
Liver transplantation for acute liver failure due to efavirenz hepatotoxicity: the importance of routine monitoring.
- Published in:
- 2013
- By:
- Publication type:
- Case Study
Impact of antiretroviral dosing frequency and pill burden on adherence among newly diagnosed, antiretroviral-naïve HIV patients.
- Published in:
- International Journal of STD & AIDS, 2012, v. 23, n. 5, p. 351, doi. 10.1258/ijsa.2011.011292
- By:
- Publication type:
- Article
Efavirenz-based combination antiretroviral therapy after peripartum single-dose nevirapine.
- Published in:
- International Journal of STD & AIDS, 2011, v. 22, n. 1, p. 38, doi. 10.1258/ijsa.2010.010229
- By:
- Publication type:
- Article
Minimum effective plasma concentration of efavirenz in treatment-naïve Chinese HIV-infected patients.
- Published in:
- International Journal of STD & AIDS, 2010, v. 21, n. 12, p. 810, doi. 10.1258/ijsa.2010.010114
- By:
- Publication type:
- Article
Changes in Liver Steatosis After Switching From Efavirenz to Raltegravir Among Human Immunodeficiency Virus– Infected Patients With Nonalcoholic Fatty Liver Disease.
- Published in:
- Clinical Infectious Diseases, 2017, v. 65, n. 6, p. 1012, doi. 10.1093/cid/cix467
- By:
- Publication type:
- Article
Adherence to Antiretroviral Therapy During and After Pregnancy: Cohort Study on Women Receiving Care in Malawi's Option B+ Program.
- Published in:
- Clinical Infectious Diseases, 2016, v. 63, n. 9, p. 1227, doi. 10.1093/cid/ciw500
- By:
- Publication type:
- Article
Long-term Treatment With Raltegravir or Efavirenz Combined With Tenofovir/ Emtricitabine for Treatment-Naive Human Immunodeficiency Virus-1-Infected Patients: 156-Week Results From STARTMRK.
- Published in:
- Clinical Infectious Diseases, 2011, v. 53, n. 8, p. 807, doi. 10.1093/cid/cir510
- By:
- Publication type:
- Article
Simultaneous Spectrophotometric Estimation of Tenofovir Disoproxil Fumarate and Lamivudine in Three Component Tablet Formulation Containing Efavirenz.
- Published in:
- Indian Journal of Pharmaceutical Sciences, 2010, v. 72, n. 4, p. 527, doi. 10.4103/0250-474X.73926
- By:
- Publication type:
- Article
How big is a macropolycyte?
- Published in:
- British Journal of Haematology, 2011, v. 155, n. 1, p. 1, doi. 10.1111/j.1365-2141.2011.08727.x
- By:
- Publication type:
- Article
Sustained HIV virologic suppression with crushed combination tablets containing elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide.
- Published in:
- American Journal of Health-System Pharmacy, 2019, v. 76, n. 16, p. 1180, doi. 10.1093/ajhp/zxz132
- By:
- Publication type:
- Article
A Comparison between the Efficiency of Vonavir (Tenofovir-EmtricitabineEfavirenz) and Cobavir (Lamivudine-Zidovudine) with Efavirenz used for HIV Patients in Fasa, Iran.
- Published in:
- Journal of Advanced Biomedical Sciences, 2022, v. 12, n. 3, p. 319, doi. 10.18502/jabs.v12i3.10717
- By:
- Publication type:
- Article
Efavirenz and psychosis: Is there a link?
- Published in:
- Australian & New Zealand Journal of Psychiatry, 2012, v. 46, n. 7, p. 687, doi. 10.1177/0004867412450474
- By:
- Publication type:
- Article
Efavirenz, emtricitabine and tenofovir tablets.
- Published in:
- WHO Drug Information, 2010, v. 24, n. 4, p. 323
- Publication type:
- Article
Optimizing Initial Therapy for HIV Infection.
- Published in:
- Journal of Infectious Diseases, 2011, v. 204, n. 8, p. 1154, doi. 10.1093/infdis/jir506
- By:
- Publication type:
- Article
Overdose of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in an HIV-1-infected subject with attempted suicide.
- Published in:
- Infection, 2019, v. 47, n. 1, p. 115, doi. 10.1007/s15010-018-1201-x
- By:
- Publication type:
- Article
Trial watch: HIV integrase inhibitor-based regimen beats market leader.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 9, p. 664, doi. 10.1038/nrd3836
- By:
- Publication type:
- Article
Anti-HIV Drugs Nevirapine and Efavirenz Affect Anxiety-Related Behavior and Cognitive Performance in Mice.
- Published in:
- Neurotoxicity Research, 2011, v. 19, n. 1, p. 73, doi. 10.1007/s12640-009-9141-y
- By:
- Publication type:
- Article
Theoretical studies on the molecular basis of HIV-1RT/NNRTIs interactions.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2011, v. 26, n. 1, p. 29, doi. 10.3109/14756360903563393
- By:
- Publication type:
- Article
Hepatocellular Carcinoma Developing in HIV/HBV Co-Infection: Case Presentation.
- Published in:
- Viral Hepatitis Journal / Viral Hepatit Dergisi, 2014, v. 20, n. 1, p. 40, doi. 10.4274/Vhd.64936
- By:
- Publication type:
- Article
Patient-reported outcomes in the single-tablet regimen (STaR) trial of rilpivirine/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir disoproxil fumarate in antiretroviral treatment-naive adults infected with HIV-1 through 48 weeks of treatment
- Published in:
- AIDS Care, 2016, v. 28, n. 3, p. 401, doi. 10.1080/09540121.2015.1096890
- By:
- Publication type:
- Article
Durability of FTC/TDF-containing cART regimens in a large cohort of HIV-infected patients seen for care in Italy.
- Published in:
- Journal of the International AIDS Society, 2012, v. 15, p. 1, doi. 10.7448/IAS.15.6.18135
- By:
- Publication type:
- Article
Elvitegravir/cobicistat/emtricitabine/tenofovir DF (Quad) has durable efficacy and differentiated safety compared to efavirenz/emtricitabine/tenofovir DF at week 96 in treatment-naïve HIV-1-infected patients.
- Published in:
- Journal of the International AIDS Society, 2012, v. 15, p. 1, doi. 10.7448/IAS.15.6.18219
- By:
- Publication type:
- Article
Switching to Atripla (EFV/FTC/TDF) from Kivexa (ABC/3TC) plus EFV leads to improved perceptions of treatment: results from the ROCKET 1 study.
- Published in:
- Journal of the International AIDS Society, 2010, v. 13, p. P42, doi. 10.1186/1758-2652-13-S4-P42
- By:
- Publication type:
- Article
Change in Vitamin D Levels Occurs Early after Antiretroviral Therapy Initiation and Depends on Treatment Regimen in Resource-Limited Settings.
- Published in:
- PLoS ONE, 2014, v. 9, n. 4, p. 1, doi. 10.1371/journal.pone.0095164
- By:
- Publication type:
- Article
Worsening Endothelial Function with Efavirenz Compared to Protease Inhibitors: A 12-Month Prospective Study.
- Published in:
- PLoS ONE, 2012, v. 7, n. 9, p. 1, doi. 10.1371/journal.pone.0045716
- By:
- Publication type:
- Article
Effects of Maraviroc and Efavirenz on Markers of Immune Activation and Inflammation and Associations with CD4<sup>+</sup> Cell Rises in HIV-Infected Patients.
- Published in:
- PLoS ONE, 2010, v. 5, n. 10, p. 1, doi. 10.1371/journal.pone.0013188
- By:
- Publication type:
- Article
Challenges for Novel Antiretroviral Development in an Era of Widespread tenofovir-disoproxil/lamivudine (or emtricitabine)/dolutegravir availability (TLD) Availability.
- Published in:
- Clinical Infectious Diseases, 2025, v. 80, n. 2, p. 434, doi. 10.1093/cid/ciae361
- By:
- Publication type:
- Article
Pre-exposure Prophylaxis Use History in People With Antiretroviral Resistance at HIV Diagnosis: Findings From New York City HIV Surveillance and Partner Services, 2015–2022.
- Published in:
- Clinical Infectious Diseases, 2024, v. 78, n. 5, p. 1240, doi. 10.1093/cid/ciad699
- By:
- Publication type:
- Article
Initial Supplementary Dose of Dolutegravir in Second-Line Antiretroviral Therapy: A Noncomparative, Double-Blind, Randomized Placebo-Controlled Trial.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 10, p. 1832, doi. 10.1093/cid/ciad023
- By:
- Publication type:
- Article
Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (TDF) Versus Efavirenz/Emtricitabine/TDF in Treatment-naive Adults With Human Immunodeficiency Virus Type 1 Infection: Week 96 Results of the Randomized, Double-blind, Phase 3 DRIVE-AHEAD Noninferiority Trial
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 1, p. 33, doi. 10.1093/cid/ciaa822
- By:
- Publication type:
- Article
Once-daily Doravirine in Human Immunodeficiency Virus Type 1–Infected, Antiretroviral-naive Adults: An Integrated Efficacy Analysis.
- Published in:
- Clinical Infectious Diseases, 2020, v. 70, n. 7, p. 1344, doi. 10.1093/cid/ciz424
- By:
- Publication type:
- Article
Reply to Lanzafame et al.
- Published in:
- 2019
- By:
- Publication type:
- Letter to the Editor
DRIVE-AHEAD Trial's Results and the Need for a More Appropriate Comparator Drug.
- Published in:
- 2019
- By:
- Publication type:
- Letter to the Editor